8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with adamantane in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inagawa, K; Miyauchi, T; Tameda, C; Uchida, H | 1 |
Fujio, M; Kuroita, T; Matsumoto, Y; Nakagawa, H; Sakai, Y | 1 |
2 other study(ies) available for 8-hydroxy-2-(di-n-propylamino)tetralin and adamantane
Article | Year |
---|---|
Pharmacological profile of (-)HT-90B, a novel 5-HT1A receptor agonist/5-HT2 receptor antagonist.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adamantane; Animals; Binding, Competitive; Buspirone; Dose-Response Relationship, Drug; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1995 |
N-[1-(2-Phenylethyl)pyrrolidin-3-yl]-1-adamantanecarboxamides as novel 5-HT2 receptor antagonists.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adamantane; Animals; Brain Chemistry; Ketanserin; Male; Molecular Structure; Platelet Aggregation Inhibitors; Pyrrolidines; Rabbits; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists | 2000 |